Cargando…
Treatment of Crohn’s disease with colony-stimulating factors: An overview
Current treatments for Crohn’s disease are aimed at suppressing excessive immune activation in the bowel walls. However, alternative strategies can be drawn. These involve the augmentation of the innate immune response, in the hypothesis that patients affected with Crohn’s disease are characterized...
Autores principales: | Guidi, Luisa, Mocci, Giammarco, Marzo, Manuela, Rutella, Sergio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621411/ https://www.ncbi.nlm.nih.gov/pubmed/19209275 |
Ejemplares similares
-
FOXP3(+) T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFα Agents
por: Guidi, Luisa, et al.
Publicado: (2013) -
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2018) -
Induction of T-cell mitogenic unresponsiveness by recombinant human granulocyte colony-stimulating factor (rHuG-CSF)
por: Rutella, S, et al.
Publicado: (2000) -
Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn’s disease
por: Gathungu, Grace, et al.
Publicado: (2018) -
The Haemopoietic Colony—Stimulating Factors
por: Mufti, G J, et al.
Publicado: (1996)